P1707: FACTORS ASSOCIATED WITH A LYMPHOMA DIAGNOSIS PRIOR TO BIOPSY by A. Ejaz, C. Harris, B. Tseu, A. A. Kirkwood, S. Bhuva, N. Taylor, C. A. Johnson, L. Wing, G. P. Collins

Get full text

P650: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BTK DEGRADER, IN PATIENTS WITH RELAPSED AND REFRACTORY B-CELL MALIGNANCIES by K. Linton, G. P. Collins, D. El-Sharkawi, R. Mous, F. Forconi, M. Tan, S. Nandakumar, E. Meredith, K. L. Jameson, S. G. Injac, J. Doorduijn

Get full text

P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHE... by M. Gleeson, C. Arias, D. Cunningham, C. Peckitt, Y. Du, N. Hujairi, Y. M. To, H.-C. Chen, S. Patel, I. Chau, P. Johnson, K. M. Ardeshna, A. Wotherspoon, A. Attygalle, E. A. Hawkes, M. P. Macheta, G. P. Collins, J. Radford, A. Forbes, A. Hart, S. Montoto, P. McKay, K. Benstead, N. Morley, N. Kalakonda, Y. Hasan, D. Turner, S. Chua

Get full text

S201: CAMIDANLUMAB TESIRINE: UPDATED EFFICACY AND SAFETY IN AN OPEN-LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) by C. Carlo-Stella, S. Ansell, P. L Zinzani, J. Radford, K. Maddocks, A. Pinto, G. P. Collins, V. Bachanova, N. Bartlett, I. Bence-Bruckler, M. Hamadani, J. Kline, J. Mayer, K. J. Savage, R. Advani, P. Caimi, R.-O. Casasnovas, T. Feldman, B. Hess, M. Bastos-Oreiro, S. Iyengar, S. Eisen, Y. Negievich, L. Wang, J. Wuerthner, A. F. Herrera

Get full text